Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis (OA) of the Knee

ClinicalTrials.gov ID: NCT01688934

Public ClinicalTrials.gov record NCT01688934. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 8:14 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Study Evaluating the Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to evaluate the analgesic efficacy of 2 dose levels of V116517 versus placebo.

Study identification

NCT ID
NCT01688934
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Purdue Pharma LP
Industry
Enrollment
230 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2012
Primary completion
May 31, 2013
Completion
Jul 31, 2013
Last update posted
Dec 4, 2013

2012 – 2013

United States locations

U.S. sites
18
U.S. states
9
U.S. cities
16
Facility City State ZIP Site status
Genova Clinical Research, Inc. Tucson Arizona 85704
Orthopedic Research Institute Boynton Beach Florida 33472
Avail Clinical Research, LLC DeLand Florida 32720
Westside Center for Clinical Research Jacksonville Florida 32205
Jacksonville Center for Clinical Research Jacksonville Florida 32216
Health Awareness, Inc. Jupiter Florida 33458
Compass Research, LLC Orlando Florida 32806
Compass Research East, LLC Oviedo Florida 32765
Northwest Indiana Center for Clinical Research Valparaiso Indiana 46383
Analgesic Solutions Natick Massachusetts 01760
Great Lakes Research Group, Inc. Bay City Michigan 48706
PMG Research of Charlotte, LLC. Charlotte North Carolina 28209
PMG Research of Raleigh, LLC Raleigh North Carolina 27609
Wake Research Associates, LLC Raleigh North Carolina 27612
LION Research Norman Oklahoma 73069
Altoona Center for Clinical Research Duncansville Pennsylvania 16635
Clinical Research Center of Reading, LLP Wyomissing Pennsylvania 19610
PMG Research of Bristol Bristol Tennessee 37620

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01688934, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 4, 2013 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01688934 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →